Welcome to our dedicated page for Nova SEC filings (Ticker: NVMI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Nova Ltd. (NVMI) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer under the Securities Exchange Act of 1934. Nova files annual reports on Form 20-F and current reports on Form 6-K, which together describe its business as a provider of material, optical and chemical metrology solutions for advanced process control in semiconductor manufacturing.
Through its Form 6-K submissions, Nova furnishes earnings releases and financial statements, including condensed consolidated balance sheets, statements of operations, and cash flows. These filings show revenues from products and services, gross profit, operating expenses, and net income, as well as discussions of non-GAAP financial measures and reconciliations. Investors can use these documents to review Nova’s performance trends and the contribution of its metrology systems and services.
Nova’s filings also cover capital structure and financing transactions. In particular, the company has filed detailed information on its 0.00% convertible senior notes due 2030, including the purchase agreement, indenture, conversion terms, redemption conditions, and ranking of the notes. Related disclosures describe capped call transactions that are intended to reduce potential dilution or offset certain cash payments upon conversion, and explain how net proceeds are allocated for general corporate purposes, potential mergers and acquisitions, business development, and new product and technology development.
Additional Form 6-K reports incorporate press releases on technology and customer milestones, such as the selection of Nova’s ELIPSON® materials metrology solution as a Tool of Record for Gate-All-Around processes, adoption of the Nova Metrion® platform, and the launch of the Nova WMC modular optical metrology platform for advanced packaging. These documents provide context on how Nova’s metrology portfolio is positioned in advanced logic, memory, and packaging applications.
On Stock Titan, users can view Nova’s latest SEC filings as they are made available from EDGAR and use AI-powered summaries to interpret complex sections, such as financing terms or segment data, making it easier to understand the implications of each filing for the company’s semiconductor metrology business.
Nova Ltd. director Oppenhaim Eitan filed a Form 3 as an initial statement of beneficial ownership of the company’s ordinary shares. The filing lists several direct holdings, with individual blocks including 3,008 ordinary shares, 2,586 ordinary shares, 1,932 ordinary shares, and 646 ordinary shares.
Footnotes clarify that these positions represent ordinary shares issuable upon vesting and settlement of restricted share units granted on May 18, 2023, June 20, 2024, and June 18, 2025. The 2023 and 2024 grants vest 25% on each anniversary of the grant date, while the 2025 grant vests 100% on the first anniversary. The document records existing equity awards rather than new open-market purchases or sales.
NOVA LTD. director Avi Cohen has filed an initial statement of beneficial ownership. The filing reports direct holdings of Ordinary Shares and vested stock options in NOVA LTD.
The holdings include Ordinary Shares, with one line showing 5,057 shares held directly, and vested options over 2,090 Ordinary Shares at an exercise price of $48.2000 per share expiring on June 24, 2027, and options over 960 Ordinary Shares at $102.3500 per share expiring on June 27, 2028.
Footnotes state that the options became fully exercisable on June 25, 2024 and June 24, 2025, and that several reported positions represent Ordinary Shares issuable upon vesting of restricted share units that vest in annual installments following their respective grant dates.
Nova Ltd. filed a Form 6-K to share a press release announcing that its Chief Financial Officer, Guy Kizner, will participate in upcoming investor conferences, including fireside chats hosted by Morgan Stanley and Cantor. Live webcasts of these sessions will be accessible through Nova’s investor relations website, and management will also hold one-on-one investor meetings arranged via banking representatives.
The company highlights its role as a leading provider of material, optical and chemical metrology solutions that help semiconductor manufacturers control advanced production processes, improve yields and shorten time to market. The release also includes forward-looking statements about anticipated growth opportunities and outlines a wide range of business risks, including geopolitical, technological, supply-chain and market uncertainties that could cause actual results to differ from expectations.
An affiliated holder of NVMI has filed a notice of proposed sale under Rule 144 for 3,125 ordinary shares, with an aggregate market value of 1,386,750.00. Shares outstanding were 31,780,111, and the approximate sale date is February 17, 2026 on Nasdaq.
The shares to be sold were originally acquired through restricted stock unit (RSU) grants from the issuer on September 1, 2021 (6,500 securities) and September 1, 2022 (4,500 securities), with no cash payment required at acquisition.
Nova Measuring Instruments ordinary shares are being prepared for sale under Rule 144. A holder has filed to potentially sell 9,346 ordinary shares through Oppenheimer & Co. on Nasdaq, with an aggregate market value of $4,147,380.96 and 31,780,111 shares outstanding.
The shares to be sold were originally acquired as restricted stock units from the issuer in two grants: 4,466 shares on 09/01/2017 and 4,880 shares on 09/01/2018, both fully paid via RSU awards rather than cash.
Nova Measuring Instruments (symbol NVMI) filed a notice of proposed insider share sales under Rule 144. The filing covers 3,046 ordinary shares to be sold through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate market value of 1351692.96.
The seller previously acquired ordinary shares from the issuer via restricted stock units (RSUs) on several dates between 09/01/2021 and 09/01/2024, in amounts of 7,000, 4,875, 3,375 and 766 shares. The filing notes 31,780,111 ordinary shares outstanding and includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.
Nova Ltd. filed a Form 6-K to inform investors that its annual report on Form 20-F, including audited consolidated financial statements for the year ended December 31, 2025, is now available on its website. Shareholders can request a hard copy of the report free of charge.
The notice is issued pursuant to Nasdaq Listing Rule 5250(d)(1)(C), which requires timely access to annual reports. Nova highlights its role as a provider of advanced metrology solutions for semiconductor manufacturing and notes that its shares trade on Nasdaq and the Tel Aviv Stock Exchange under the ticker NVMI.
Nova Ltd., an Israel-based semiconductor metrology equipment maker, filed its annual report outlining its 2025 business profile, capital structure and extensive risk factors. The company had 31,780,111 ordinary shares outstanding as of December 31, 2025 and its shares trade on the Nasdaq Global Select Market under the symbol NVMI.
The report highlights heavy exposure to global chip cycles, concentrated sales to a small group of major customers and strong dependence on a few core product lines. Nova details rising cybersecurity threats, complex export controls and tariffs affecting sales to Chinese semiconductor manufacturers, and operational concentration in manufacturing facilities in Israel, the U.S. and Germany. It also notes geopolitical risks tied to Israel, including the 2023–2025 conflicts and potential judicial changes, as well as compliance burdens from evolving ESG and data-privacy rules.
Nova discloses a $750 million 0% convertible senior notes due 2030 issuance, which can dilute shareholders upon conversion and may constrain future strategic transactions. The company also describes a new ERP system launched in January 2026 and the completed acquisition of Sentronics Metrology GmbH, both of which introduce integration and execution risks alongside growth opportunities.
Nova Ltd. reported strong fourth-quarter and record full-year 2025 results. Q4 2025 revenue was $222.6 million, up 14% from Q4 2024 and down 1% sequentially, with GAAP diluted EPS of $1.94 versus $1.58 a year earlier.
For full-year 2025, revenue reached $880.6 million, up 31% from $672.4 million in 2024. GAAP net income rose to $259.2 million, with diluted EPS of $7.96 compared with $5.75 in 2024. Non-GAAP diluted EPS increased to $8.62 from $6.69, reflecting higher profitability.
Gross margin was 57.4% in 2025, similar to 57.6% in 2024, while non-GAAP operating margin held at 33%. Management described 2025 as an exceptional year and expects Q1 2026 GAAP diluted EPS of $1.90–$2.02 and non-GAAP diluted EPS of $2.13–$2.25.
Wasatch Advisors filed Amendment No. 8 to a Schedule 13G reporting beneficial ownership of 1,338,123 shares of Nova Ltd, representing 4.6% of the class as of 12/31/2025. Wasatch has sole voting power over 910,149 shares and sole dispositive power over all 1,338,123 shares.
The firm certifies the shares were acquired and are held in the ordinary course of business, and not for the purpose or effect of changing or influencing control of Nova Ltd.